PolitiFact - Moderna’s lawsuits against Pfizer do not prove the COVID-19 vaccine existed before the pandemic

Indonesia Berita Berita

PolitiFact - Moderna’s lawsuits against Pfizer do not prove the COVID-19 vaccine existed before the pandemic
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 PolitiFact
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 71%

Scientists used mRNA technology to study other viruses before COVID-19. Moderna is suing Pfizer-BioNTech for infringing patents on mRNA technology filed between 2010 and 2016.

from dead and inactivated viruses or parts of a living virus that have been weakened.two patent infringement lawsuits, alleging that Pfizer and BioNTech had used key features of Moderna’s technology to make their own COVID-19 vaccine. One lawsuit was filed in District Court in Massachusetts, where Moderna is based; the other was filed in Germany, where BioNTech is headquartered.

In October 2020, Moderna pledged not to enforce its patents related to COVID-19 while the pandemic continued, the company said in a. Last March, Moderna updated its policy to continue exempting low- and middle-income countries from its COVID-19 patent enforcement. But Moderna said it expects companies like Pfizer and BioNTech to respect its intellectual property rights.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

PolitiFact /  🏆 17. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Scientists question Moderna invention claim in COVID-19 vaccine disputeThe makers of the two most widely used COVID19 vaccines in the United States are now in a patent fight over their shots.
Baca lebih lajut »

Moderna patent fight about feathers, not gooseModerna patent fight about feathers, not gooseModerna’s claim that the Covid-19 vaccine developed by Pfizer and partner BioNTech used its intellectual property sounds explosive. The sums at stake are potentially huge, as the drug giant estimates sales of the vaccine will be $32 billion this year. It’s in nobody’s interest to kill this golden goose though. The most likely result will simply be lots of legal hissing, and at worst for Pfizer, a few plucked feathers.
Baca lebih lajut »

Pfizer's RSV vaccine candidate over 85% effective in older adults, data showsPfizer's RSV vaccine candidate over 85% effective in older adults, data showsPfizer announced Thursday that its vaccine candidate for respiratory syncytial virus was 85.7% effective in preventing lower respiratory tract illness in older adults.
Baca lebih lajut »

PolitiFact - Recycled claim is still false: The COVID-19 pandemic was not plannedPolitiFact - Recycled claim is still false: The COVID-19 pandemic was not plannedTwitter users reposted a 2020 video clip of rapper Pitbull claiming the COVID-19 pandemic had been rehearsed at a 2019 simulation. The claim was debunked then, and remains untrue.
Baca lebih lajut »



Render Time: 2025-04-22 22:01:37